Areeg Faggad

542 total citations
18 papers, 406 citations indexed

About

Areeg Faggad is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Areeg Faggad has authored 18 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Areeg Faggad's work include MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (4 papers) and Global Cancer Incidence and Screening (3 papers). Areeg Faggad is often cited by papers focused on MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (4 papers) and Global Cancer Incidence and Screening (3 papers). Areeg Faggad collaborates with scholars based in Sudan, Germany and France. Areeg Faggad's co-authors include Wilko Weichert, Carsten Denkert, Manfred Dietel, Silvia Darb‐Esfahani, Jan Budczies, Berit Müller, Nasr Eldin Elwali, Aurelia Noske, Jalid Sehouli and Bruno V. Sinn and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Pathology and Modern Pathology.

In The Last Decade

Areeg Faggad

17 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Areeg Faggad Sudan 12 268 164 96 44 33 18 406
Chengjuan Jin China 13 216 0.8× 116 0.7× 79 0.8× 69 1.6× 25 0.8× 21 420
Wen Yuan China 12 232 0.9× 155 0.9× 49 0.5× 39 0.9× 16 0.5× 28 368
Sara Moufarrij United States 6 275 1.0× 107 0.7× 113 1.2× 61 1.4× 17 0.5× 14 428
Xinyuan Yang China 11 251 0.9× 146 0.9× 59 0.6× 65 1.5× 21 0.6× 28 480
Monica Dandapani United States 7 200 0.7× 154 0.9× 97 1.0× 83 1.9× 41 1.2× 14 396
Ayako Kim Japan 6 271 1.0× 119 0.7× 116 1.2× 140 3.2× 21 0.6× 6 443
Juan Lin China 9 235 0.9× 111 0.7× 81 0.8× 19 0.4× 16 0.5× 14 365
Eun Ji Choi South Korea 11 179 0.7× 81 0.5× 83 0.9× 20 0.5× 26 0.8× 24 331
Yongchu Sun China 9 194 0.7× 135 0.8× 99 1.0× 17 0.4× 20 0.6× 14 313
Renba Liang China 10 212 0.8× 150 0.9× 145 1.5× 18 0.4× 19 0.6× 14 400

Countries citing papers authored by Areeg Faggad

Since Specialization
Citations

This map shows the geographic impact of Areeg Faggad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Areeg Faggad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Areeg Faggad more than expected).

Fields of papers citing papers by Areeg Faggad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Areeg Faggad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Areeg Faggad. The network helps show where Areeg Faggad may publish in the future.

Co-authorship network of co-authors of Areeg Faggad

This figure shows the co-authorship network connecting the top 25 collaborators of Areeg Faggad. A scholar is included among the top collaborators of Areeg Faggad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Areeg Faggad. Areeg Faggad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Elhassan, Moawia Mohammed Ali, et al.. (2023). Clinicopathological profile and management of thyroid carcinoma: a Sub-Saharan country experience. Thyroid Research. 16(1). 35–35. 4 indexed citations
3.
Faggad, Areeg, et al.. (2022). Increased Fasting Plasma Glucose and Breast Cancer Risk in Sudanese Women: Association with Premenopausal Status and High Body Mass Index. SHILAP Revista de lepidopterología. 7(4). 289–295. 1 indexed citations
4.
David, Stéphanie, et al.. (2022). Nanoparticles design considerations to co-deliver nucleic acids and anti-cancer drugs for chemoresistance reversal. International Journal of Pharmaceutics X. 4. 100126–100126. 30 indexed citations
5.
David, Stéphanie, et al.. (2022). Formulation of Lipid-Based Nanoparticles for Simultaneous Delivery of Lapatinib and Anti-Survivin siRNA for HER2+ Breast Cancer Treatment. Pharmaceuticals. 15(12). 1452–1452. 7 indexed citations
6.
Faggad, Areeg, et al.. (2022). Relapse-free survival in Sudanese women with non-metastatic breast cancer. SHILAP Revista de lepidopterología. 4. 100082–100082. 1 indexed citations
7.
Allard-Vannier, Émilie, Katel Hervé-Aubert, Nicolas Aubrey, et al.. (2022). Combination of Nanovectorized siRNA Directed against Survivin with Doxorubicin for Efficient Anti-Cancer Activity in HER2+ Breast Cancer Cells. Pharmaceutics. 14(11). 2537–2537. 14 indexed citations
8.
Elhassan, Moawia Mohammed Ali, et al.. (2021). Survival Outcomes of Breast Cancer in Sudanese Women: A Hospital-Based Study. JCO Global Oncology. 7(7). 324–332. 13 indexed citations
9.
Faggad, Areeg, et al.. (2020). Characteristics of Breast Cancer at First Presentation in Sudanese Patients Attending the National Cancer Institute–University of Gezira (NCI–UG). SHILAP Revista de lepidopterología. 104–110. 6 indexed citations
10.
Faggad, Areeg, et al.. (2015). C-reactive protein is associated with low-density lipoprotein cholesterol and obesity in type 2 diabetic Sudanese. Diabetes Metabolic Syndrome and Obesity. 8. 427–427. 24 indexed citations
11.
Faggad, Areeg, Atsuko Kasajima, Wilko Weichert, et al.. (2012). Down‐regulation of the microRNA processing enzyme Dicer is a prognostic factor in human colorectal cancer. Histopathology. 61(4). 552–561. 43 indexed citations
12.
Faggad, Areeg, Silvia Darb‐Esfahani, Ralph M. Wirtz, et al.. (2009). Expression of multidrug resistance‐associated protein 1 in invasive ovarian carcinoma: implication for prognosis. Histopathology. 54(6). 657–666. 24 indexed citations
13.
Faggad, Areeg, Silvia Darb‐Esfahani, Ralph M. Wirtz, et al.. (2009). Topoisomerase IIα mRNA and protein expression in ovarian carcinoma: correlation with clinicopathological factors and prognosis. Modern Pathology. 22(4). 579–588. 32 indexed citations
14.
Noske, Aurelia, Areeg Faggad, Silvia Darb‐Esfahani, et al.. (2009). IMP3 Expression in Human Ovarian Cancer is Associated With Improved Survival. International Journal of Gynecological Pathology. 28(3). 203–210. 25 indexed citations
15.
Darb‐Esfahani, Silvia, Ralph M. Wirtz, Bruno V. Sinn, et al.. (2009). Estrogen receptor 1 mRNA is a prognostic factor in ovarian carcinoma: determination by kinetic PCR in formalin-fixed paraffin-embedded tissue. Endocrine Related Cancer. 16(4). 1229–1239. 30 indexed citations
16.
Faggad, Areeg, Jan Budczies, Oleg Tchernitsa, et al.. (2009). Prognostic significance of Dicer expression in ovarian cancer—link to global microRNA changes and oestrogen receptor expression. The Journal of Pathology. 220(3). 382–391. 74 indexed citations
17.
Sinn, Bruno V., Silvia Darb‐Esfahani, Ralph M. Wirtz, et al.. (2009). Vascular endothelial growth factor C mRNA expression is a prognostic factor in epithelial ovarian cancer as detected by kinetic RT-PCR in formalin-fixed paraffin-embedded tissue. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 455(6). 461–467. 13 indexed citations
18.
Darb‐Esfahani, Silvia, Areeg Faggad, Aurelia Noske, et al.. (2008). Phospho-mTOR and phospho-4EBP1 in endometrial adenocarcinoma: association with stage and grade in vivo and link with response to rapamycin treatment in vitro. Journal of Cancer Research and Clinical Oncology. 135(7). 933–941. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chengjuan Jin Breakdown of academic impact, for papers by Wen Yuan Breakdown of academic impact, for papers by Sara Moufarrij Breakdown of academic impact, for papers by Xinyuan Yang Breakdown of academic impact, for papers by Monica Dandapani Breakdown of academic impact, for papers by Ayako Kim Breakdown of academic impact, for papers by Juan Lin Breakdown of academic impact, for papers by Eun Ji Choi Breakdown of academic impact, for papers by Yongchu Sun Breakdown of academic impact, for papers by Renba Liang
Rankless by CCL
2026